top of page
  • Writer's pictureSBIJI Innovation

Orasis CEO and Chairman Share Their Strategies for Success

May 6, 2020

Elad Kedar, CEO of Orasis Pharmaceuticals shares his strategy for successfully completing a Phase 2b clinical study in preparation of their phase 3 of CSF-1 drops for temporary correction of presbyopia. Jeffry Weinhuff from Visionary Ventures joins the conversation as Chairman of the Board to explain how he evaluated the Orasis technology and what VCs look for.

6 views0 comments

Recent Posts

See All


bottom of page